Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.
about
Treatment of chronic graft-versus-host disease in 2011Novel applications of Rituximab in dermatological disordersAlteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studyImmunohistochemistry of affected tissue may guide cGVHD treatment decisions.Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II studyEffectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host diseaseThe role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.Treatment of graft-versus-host disease with monoclonal antibodies and related fusion proteins.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy.Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options.Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.Towards a rational graft-versus-host disease (GVHD) prophylaxis: rituximab should not be forgotten.A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
P2860
Q26851433-9E9D6C37-0C49-4DA8-89E7-52A6AD2476B0Q34087599-6EE916D3-BF44-4866-A581-4FD2912CD2F3Q34109382-03C54FD6-80CE-46F2-892F-172618B0757BQ34255166-F723204A-2FF4-4E2A-8E7F-13F3379E4499Q34609019-FBFDA75D-59E3-4046-8E12-80E12D7691BFQ35140097-049413A3-0CD8-4EA7-933A-C145884231FDQ35193763-5F1A60D3-CEDF-4F2F-89A1-CE50CF80F1F4Q35930604-A80B2807-35E6-48DF-9206-C7E47B69A68EQ37689179-3F0CF2DA-79BB-4AEB-B324-EE84CF77EC51Q37810286-5B523C9B-D595-4D9E-9C46-1E10B4ED9850Q37843939-AB511E9F-F6BC-4EC8-9807-2E8C883A44EEQ37899200-67E1C807-B95D-4CE4-AC68-EA9ADA42691CQ37923305-1A4107D1-990F-4EFB-825A-F4EECC25E65BQ38066586-8058C1E3-20F4-4367-A9CC-D1F8761F0A60Q38416371-EAD80547-A56E-47FE-9E19-3712B21BC490Q40892130-15655317-0629-4757-9DE8-E22BA61408F2Q41791356-A3A46B64-B1CC-4673-89CE-F078C470F302Q52971841-91708EEA-D9E6-49E9-811D-A6E21BE00188Q54546815-B0DEAE3C-2627-4186-9349-E46ED38BEDA3
P2860
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rituximab for the treatment of ...... nic graft-versus-host disease.
@ast
Rituximab for the treatment of ...... nic graft-versus-host disease.
@en
type
label
Rituximab for the treatment of ...... nic graft-versus-host disease.
@ast
Rituximab for the treatment of ...... nic graft-versus-host disease.
@en
prefLabel
Rituximab for the treatment of ...... nic graft-versus-host disease.
@ast
Rituximab for the treatment of ...... nic graft-versus-host disease.
@en
P2093
P1476
Rituximab for the treatment of ...... nic graft-versus-host disease.
@en
P2093
Hideho Henzan
Katsuto Takenaka
Ken Takase
Koichi Akashi
Koichi Miyamura
Koji Nagafuji
Michihiro Hidaka
Mine Harada
Toshihiro Miyamoto
P2888
P304
P356
10.1007/S12185-009-0370-X
P577
2009-06-20T00:00:00Z
P6179
1052880400